Immunology of diabetes society T-cell workshop: HLA class II tetramer-directed epitope validation initiative

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 727-736

  James, E A ^a   Mallone, R ^b   Schloot, N C ^c,d   Gagnerault, M C ^b   Thorpe, J ^a   Fitzgerald Miller, L ^e   Reichow, J ^f   Wagner, R ^e   Pham, M N ^c   Jospe, N ^g   Lou, O ^h   Gottlieb, P A ^e   Brooks Worrell, B M ⁱ   Durinovic Belló, Ivana ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF COLORADO DENVER   (United States)

^f Seattle Institute for Biomedical and Clinical Research   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^h Juvenile Diabetes Research Foundation International   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antigens peptides epitopes; GAD65; Proinsulin; T cells; Type 1 diabetes; Validation

Indexed keywords

GLUTAMATE DECARBOXYLASE; PROINSULIN;

ADULT; ARTICLE; CELL CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY OF DIABETES SOCIETY T CELL WORKSHOP; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MULTICENTER STUDY; PRIORITY JOURNAL; VALIDATION PROCESS; WORKSHOP;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; PROINSULIN;

EID: 80755176919     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1244     Document Type: Article

References (30)

1. Skyler JS. Prediction and prevention of type 1 diabetes: progress, problems, and prospects. Clin Pharmacol Ther 2007; 81(5): 768-771.
2. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW. Autoreactive T cells in healthy individuals. J Immunol 2004; 172(10): 5967-5972.
3. Arif S, Tree TI, Astill TP, et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113(3): 451-463.
4. Durinovic-Belló I, Schlosser M, Riedl M, et al. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 type 1 diabetes. Diabetologia 2004; 47(3): 439-450.
5. Monti P, Scirpoli M, Rigamonti A, et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol 2007; 179(9): 5785-5792.
6. Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 2002; 109(7): 895-903.
7. Yang J, Danke N, Roti M, et al. CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J Autoimmun 2008; 31(1): 30-41.
8. Di Lorenzo TP, Peakman M, Roep BO. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 2007; 148(1): 1-16.
9. Kelemen K. The role of T cells in beta cell damage in NOD mice and humans. Adv Exp Med Biol 2004; 552: 117-128.
10. Wicker LS, Chen SL, Nepom GT, et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1996; 98(11): 2597-2603.
11. Congia M, Patel S, Cope AP, De Virgiliis S, Sonderstrup G. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci U S A 1998; 95(7): 3833-3838.
12. Alleva DG, Gaur A, Jin L, et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 2002; 51(7): 2126-2134.
13. Krishnamurthy B, Dudek NL, McKenzie MD, et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006; 116(12): 3258-3265.
14. Devendra D, Miao D, Nakayama M, Eisenbarth GS, Liu E. Pancreatic autoimmunity induction with insulin B:9-23 peptide and viral mimics in the NZB mouse. Ann N Y Acad Sci 2006; 1079: 135-137.
15. Tree TI, Peakman M. Autoreactive T cells in human type 1 diabetes. Endocrinol Metab Clin North Am 2004; 33(1): 113-133.
16. Lieberman SM, DiLorenzo TP. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 2003; 62(5): 359-377.
17. Seyfert-Margolis V, Gisler TD, Asare AL, et al. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 2006; 55(9): 2588-2594.
18. Nagata M, Kotani R, Moriyama H, Yokono K, Roep BO, Peakman M. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop. Ann N Y Acad Sci 2004; 1037: 10-15.
19. Roep BO, Atkinson MA, van-Endert PM, Gottlieb PA, Wilson SB, Sachs JA. Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J Autoimmun 1999; 13(2): 267-282.
20. Schloot N, Meierhoff G, Faresjo M, et al. Comparison of cytokine assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003; 21(4): 365-376.
21. Herold KC, Brooks-Worrell B, Palmer J, et al. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009; 58(11): 2588-2595.
22. Durinovic-Belló I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun 2010; 11(2): 188-193.
23. Novak EJ, Liu AW, Nepom GT, Kwok WW. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Invest 1999; 104(12): R63-R67.
24. Ettinger RA, Kwok WW. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J Immunol 1998; 160(5): 2365-2373.
25. Yang J, Danke NA, Berger D, et al. Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol 2006; 176(5): 2781-2789.
26. Mallone R, Mannering SI, Brooks-Worrell BM, et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol 2011; 163(1): 33-49.
27. Mannering SI, Wong FS, Durinovic-Bello I, et al. Current approaches to measuring human islet antigen specific T cell function in type 1 diabetes. Clin Exp Immunol 2010; 162(2): 197-209.
28. Schloot NC, Meierhoff G, Karlsson Faresjo M, et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003; 21(4): 365-376.
29. Brooks-Worrell B, Gersuk VH, Greenbaum C, Palmer JPP. Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes. J Immunol 2001; 166(8): 5265-5270.
30. Oling V, Marttila J, Ilonen J, et al. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun 2005; 25(3): 235-243.